Stratton Management’s West Pharmaceutical WST Stock Holding History

Stratton Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-702,900	Closed	-$40.8M	–	301
2015 Q2	$40.8M	Hold	702,900	–	–	1.78%	1
2015 Q1	$42.3M	Hold	702,900	–	–	1.72%	3
2014 Q4	$37.4M	Buy	702,900 +2,800	+0.4%	+$140K	1.54%	2
2014 Q3	$31.3M	Sell	700,100 -2,800	-0.4%	-$119K	1.41%	5
2014 Q2	$29.6M	Buy	702,900 +67,900	+11%	+$2.91M	1.23%	14
2014 Q1	$28M	Hold	635,000	–	–	1.29%	13
2013 Q4	$31.2M	Hold	635,000	–	–	1.48%	6
2013 Q3	$26.1M	Buy	635,000 +2,800	+0.4%	+$107K	1.35%	9
2013 Q2	$22.2M	Buy	+632,200	New	+$20.8M	1.29%	8

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Stratton Management's WST Position: Q3 2015 in Review

Stratton Management sold out of West Pharmaceutical (WST) in Q3 2015, closing a stake of 702,900 shares — an estimated $40.8M sold.

Stratton Management first reported a position in WST in Q2 2013 and held it in 9 quarters. The position peaked at $42.3M in Q1 2015. 248 funds tracked by Wall St. Rank hold WST as of Q3 2015.

Stratton Management reported no remaining West Pharmaceutical position as of Q3 2015 after selling out during the quarter.
Stratton Management sold 702,900 West Pharmaceutical shares in Q3 2015, an estimated $40.8M.
Stratton Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 9 quarters.
Stratton Management's West Pharmaceutical position peaked at $42.3M in Q1 2015.
248 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2015.

Based on Stratton Management's 13F filing for Q3 2015, filed 6 Nov 2015.